
Oatmeal Health is an AI-powered cancer screening platform that collaborates with Federally Qualified Health Centers (FQHCs) and health systems to improve cancer detection outcomes in underserved communities. They operate on a revenue-sharing model, providing their services at no cost to FQHCs. The platform deploys virtual teams of nurses and radiologists to facilitate early cancer detection, manage screenings, and enhance patient outcomes through AI risk assessments, care navigation, and advanced diagnostics like liquid biopsy blood tests. Oatmeal Health also supports clinical trial enrollment and generates new fee-for-service and value-based reimbursements for FQHCs by managing the screening process and adherence.

Oatmeal Health is an AI-powered cancer screening platform that collaborates with Federally Qualified Health Centers (FQHCs) and health systems to improve cancer detection outcomes in underserved communities. They operate on a revenue-sharing model, providing their services at no cost to FQHCs. The platform deploys virtual teams of nurses and radiologists to facilitate early cancer detection, manage screenings, and enhance patient outcomes through AI risk assessments, care navigation, and advanced diagnostics like liquid biopsy blood tests. Oatmeal Health also supports clinical trial enrollment and generates new fee-for-service and value-based reimbursements for FQHCs by managing the screening process and adherence.
What they do: AI-powered lung cancer screening and virtual cancer clinic serving FQHCs and health systems
Business model: Revenue-sharing with FQHCs; provides services at no cost to FQHCs while generating fee-for-service and value-based reimbursements
Tech: AI CADx for lung nodule risk stratification (LungAI) and integrations with CADe/EHR systems
Founded: 2022
Recent funding: Pre-Seed round announced Mar 15, 2024
Early cancer detection and care access disparities in underserved communities (community health centers / FQHCs).
2022
Hospitals and Health Care
Angel round announced Oct 22, 2023; reported investors include Vishisht Mehta, Reetu Gupta, Meric Cavanaugh; reported pre‑money valuation $8.5M
Pre-Seed round announced Mar 15, 2024; investors reported to include Vye Ventures and CancerX Startup Accelerator
“Has angel and early‑stage institutional investors including individual angels and accelerators (e.g., Vye Ventures, CancerX Startup Accelerator, and listed individual angels)”
| Company |
|---|
We are seeking a dedicated Nuclear Medicine Technologist in Lincoln, Nebraska, to perform diagnostic imaging procedures using radioactive materials.
Responsibilities include preparing and administering radiopharmaceuticals, operating imaging equipment, and ensuring patient safety and comfort.
Skills required include strong attention to detail, excellent communication, and knowledge of radiation safety protocols.
Additional duties involve maintaining accurate records and collaborating with healthcare teams.
Benefits include competitive salary, health insurance, retirement plans, paid time off, and professional development opportunities.
Join us to make a difference in patient care through advanced imaging technology.